Fowler C J, Oreland L, Marcusson J, Winblad B
Naunyn Schmiedebergs Arch Pharmacol. 1980 Apr;311(3):263-72. doi: 10.1007/BF00569406.
The interaction of clorgyline and L-deprenil with the -A and -B forms of human brain monoamine oxidase (MAO) has been studied. Both compounds inhibit cerebrocortical MAO in a manner consistent with a 'suicide' inactivation of the enzyme. The interaction of clorgyline with the -A form of the enzyme appears to take place almost entirely at specific binding sites, and the conditions required for this inhibitor to 'titrate' the concentrations of MAO-A have been elucidated. L-Deprenil has also been used to titrate the concentration of the -B form of MAO in cerebrocortical homogenates, but there is a considerable degree of non-specific binding of this compound. The two inhibitors have been used to titrate the concentrations of the two enzyme forms in frontal cortex homogenates from different age groups. There was a significantly higher MAO-B activity for the age range 73--95 years than for the age range 2--63 years. No significant differences between the two age groups were found for MAO-A. The activity of MAO-A in the samples correlated very well with the concentration of this enzyme form. Titration of the B-form of the enzyme with L-deprenil indicated an increased enzyme concentration with age, although other factors, such as the non-specific binding of this compound, could contribute to this effect.
已对氯吉兰和L-司来吉兰与人脑单胺氧化酶(MAO)的-A和-B形式之间的相互作用进行了研究。两种化合物均以与该酶的“自杀性”失活相一致的方式抑制脑皮质MAO。氯吉兰与该酶的-A形式之间的相互作用似乎几乎完全发生在特定结合位点,并且已经阐明了该抑制剂“滴定”MAO-A浓度所需的条件。L-司来吉兰也已用于滴定脑皮质匀浆中MAO的-B形式的浓度,但该化合物存在相当程度的非特异性结合。这两种抑制剂已用于滴定来自不同年龄组的额叶皮质匀浆中两种酶形式的浓度。73 - 95岁年龄组的MAO-B活性显著高于2 - 63岁年龄组。MAO-A在两个年龄组之间未发现显著差异。样品中MAO-A的活性与该酶形式的浓度相关性非常好。用L-司来吉兰滴定该酶的B形式表明,尽管其他因素(如该化合物的非特异性结合)可能导致这种效应,但酶浓度随年龄增加。